From Nasdaq

May 6, 2025 10:29:00 AM:

Barclays issued an ‘Overweight’ rating for $MSTR, with 3 buy ratings and 1 sell rating from other firms in recent months. The stock has a median price target of $395.0, with analysts like Monness setting targets at $220.0 and BTIG at $570.0. Congress and insiders have also been active in trading $MSTR stock.

Congress members have made 2 purchases of $MSTR stock in the last 6 months, while insiders have conducted 53 trades, with 3 purchases and 50 sales. Notable insiders like STEPHEN X GRAHAM, ANDREW KANG, and PHONG LE have made significant transactions. Hedge funds have shown mixed activity, with 646 adding shares and 304 decreasing their positions.

Institutions like CAPITAL INTERNATIONAL INVESTORS and MORGAN STANLEY have reduced their holdings, while others like UBS GROUP AG and BLACKROCK, INC. have increased their positions. To track all these activities, visit Quiver Quantitative’s platforms for detailed information. This news was originally published on Quiver News, highlighting the latest insights on $MSTR.

Read more at Nasdaq, Inc.: New Analyst Forecast: $MSTR Given ‘Overweight’ Rating